|
|
| ICH E6(R3): What's Critical To TMF Quality | Guest Column | By Ken Keefer, MBA, PMP, Keefer Consulting Inc. | By applying Quality by Design to clinical trials, sponsor companies can rise to meet the elevated role and importance of the TMF in the face of ICH E6 (RF3). |
|
|
|
|
| Advancing Development Of New Oncology Therapies | Webinar | Veristat, Inc. | Learn how the FDA's Project FrontRunner expedites cancer drug approval for early advanced metastatic cancer, emphasizing efficacy and safety in earlier clinical settings. |
|
|
|
|
|
|
| Key Considerations In Choosing A Technology Partner | Article | Mednet | When choosing a technology partner, CROs should consider the partner's experience in the clinical research industry, ability to meet the CRO's specific needs, commitment to quality, and more. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|